chr3-50343751-AG-A
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_015896.4(ZMYND10):βc.300delβ(p.Phe101SerfsTer38) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,614,032 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.0000066 ( 0 hom., cov: 33)
Exomes π: 0.000017 ( 0 hom. )
Consequence
ZMYND10
NM_015896.4 frameshift
NM_015896.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.332
Genes affected
ZMYND10 (HGNC:19412): (zinc finger MYND-type containing 10) This gene encodes a protein containing a MYND-type zinc finger domain that likely functions in assembly of the dynein motor. Mutations in this gene can cause primary ciliary dyskinesia. This gene is also considered a tumor suppressor gene and is often mutated, deleted, or hypermethylated and silenced in cancer cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 3-50343751-AG-A is Pathogenic according to our data. Variant chr3-50343751-AG-A is described in ClinVar as [Pathogenic]. Clinvar id is 66022.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZMYND10 | NM_015896.4 | c.300del | p.Phe101SerfsTer38 | frameshift_variant | 3/12 | ENST00000231749.8 | NP_056980.2 | |
ZMYND10 | NM_001308379.2 | c.300del | p.Phe101SerfsTer38 | frameshift_variant | 3/11 | NP_001295308.1 | ||
ZMYND10 | XM_005265216.4 | c.63del | p.Phe22SerfsTer38 | frameshift_variant | 2/11 | XP_005265273.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZMYND10 | ENST00000231749.8 | c.300del | p.Phe101SerfsTer38 | frameshift_variant | 3/12 | 1 | NM_015896.4 | ENSP00000231749 | P1 | |
ZMYND10-AS1 | ENST00000440013.1 | n.124-1818del | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152166Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152166
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461866Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727236
GnomAD4 exome
AF:
AC:
25
AN:
1461866
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
727236
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152166Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74328
GnomAD4 genome
AF:
AC:
1
AN:
152166
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Primary ciliary dyskinesia 22 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 08, 2013 | - - |
Primary ciliary dyskinesia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 09, 2022 | This sequence change creates a premature translational stop signal (p.Phe101Serfs*38) in the ZMYND10 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ZMYND10 are known to be pathogenic (PMID: 23891469, 23891471). This variant is present in population databases (rs587777043, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with primary ciliary dyskinesia (PMID: 23891469). ClinVar contains an entry for this variant (Variation ID: 66022). For these reasons, this variant has been classified as Pathogenic. - |
ZMYND10-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 29, 2023 | The ZMYND10 c.300delC variant is predicted to result in a frameshift and premature protein termination (p.Phe101Serfs*38). This variant has been reported in the homozygous state or heterozygous state with a second ZMYND10 variant in a study of individuals with primary ciliary dyskinesia or situs inversus (Zariwala et al. 2013. PubMed ID: 23891469). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in ZMYND10 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at